Pretransplant Hepatic Malignancy Increases Risk of De Novo Malignancy after Liver Transplantation

Gil-Chun PARK; Shin HWANG; Chul-Soo AHN; Ki-Hun KIM; Deok-Bog MOON; Tae-Yong HA; Gi-Won SONG; Dong-Hwan JUNG; Young-In YOON; Hui-Dong CHO; Jae-Hyun KWON; Yong-Kyu CHUNG; Sang-Hyun KANG; Jin-Uk CHOI; I-Ji JUNG; Sung-Gyu LEE.
Journal of Korean Medical Science ; : 69-2020.
Artículo en Inglés | WPRIM | ID: wpr-810941

Documentos relacionados

  1. Pretransplant Hepatic Malignancy Increases Risk of De Novo Malignancy after Liver Transplantation.
  2. Pretransplant Hepatic Malignancy Increases Risk of De Novo Malignancy after Liver Transplantation
  3. Pretransplant Hepatic Malignancy Increases Risk of De Novo Malignancy after Liver Transplantation
  4. Cancer statistics, 2024.
  5. High rates of de novo malignancy compromise post-heart transplantation survival.
  6. Incidence and Outcomes of Early Cancers After Kidney Transplantation.
  7. A Comprehensive Landscape of <i>De Novo</i> Malignancy After Double Lung Transplantation.
  8. Increased incidence rates of positive blood cultures shortly after chemotherapy compared to radiotherapy among individuals treated for solid malignant tumours.
  9. Impact of Propofol-based Total Intravenous Anesthesia Versus Inhalation Anesthesia on Long-term Survival After Cancer Surgery in a Nationwide Cohort.
  10. Cancer Statistics, 2021.